curculigoside has been researched along with Colitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ding, X; Huang, H; Ji, L; Jiang, J; Li, F; Lu, D; Zhao, P | 1 |
1 other study(ies) available for curculigoside and Colitis
Article | Year |
---|---|
Curculigoside mitigates dextran sulfate sodium‑induced colitis by activation of KEAP1‑NRF2 interaction to inhibit oxidative damage and autophagy of intestinal epithelium barrier.
Topics: Animals; Autophagy; Caco-2 Cells; Colitis; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Humans; Hydrogen Peroxide; Intestinal Mucosa; Kelch-Like ECH-Associated Protein 1; Mice; NF-E2-Related Factor 2; Oxidative Stress; Tumor Necrosis Factor-alpha | 2023 |